Nadine B.
- Country
- Germany
- Department
- Global Clinical Development & Operations
Research Overview
- Pharmacokinetic Evaluation of Three BI 764198 Formulations in Healthy Volunteers: Impact of Food on Drug Absorption
- Evaluation of BI 3000202 on Pharmacokinetics of Rosuvastatin and Digoxin in Healthy Volunteers
- Pharmacokinetic Interaction Study of Vicadrostat and Empagliflozin in Healthy Male Volunteers
Data & Insights
Has run more than one trial at 1 of 1 partner site.
Specializations
Clinical Pharmacology
The investigator specializes in conducting pharmacokinetic studies to understand how different drug formulations are processed by the human body. Their expertise includes evaluating bioavailability and drug absorption patterns in healthy individuals.
- Drug formulation assessment
- Food-drug interaction studies
- Bioavailability research
Their work contributes to understanding how dietary factors influence medication effectiveness.
Clinical Research Methodology
The investigator focuses on conducting healthy volunteer trials as a crucial step in understanding new therapeutic compounds. Their expertise includes studying drug metabolism and absorption patterns in controlled research settings.
- Comparative formulation studies
- Metabolic assessment
- Safety evaluation
Their research emphasizes the importance of understanding drug behavior in healthy populations.
Pharmaceutical Sciences
The investigator's work encompasses the evaluation of multiple drug formulations and their impact on therapeutic effectiveness. They specialize in studying pharmacological properties of investigational compounds.
- Formulation optimization
- Drug delivery systems
- Absorption mechanisms
Their research aids in optimizing drug formulations for improved therapeutic outcomes.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.